There is evidence that oxidative stress may reduce corticosteroid sensitivity in COPD by mechanisms involving phosphorylation of the glucocorticoid receptor (GR) as well as phosphorylation and inactivation of histone deacetylase-2 (HDAC-2) [38–41]. The gene discussed is HDAC2; the disease is chronic obstructive pulmonary disease.